東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

TRAF1 in Human Health and Disease.

Edilova, Maria .

FindBook

Google Book

Amazon

博客來

TRAF1 in Human Health and Disease.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	TRAF1 in Human Health and Disease./
作者:	Edilova, Maria .
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	175 p.
附註:	Source: Dissertations Abstracts International, Volume: 81-05, Section: B.
Contained By:	Dissertations Abstracts International81-05B.
標題:	Immunology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27540072
ISBN:	9781392634585

TRAF1 in Human Health and Disease.
Edilova, Maria .

TRAF1 in Human Health and Disease. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 175 p.

Source: Dissertations Abstracts International, Volume: 81-05, Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2019.

This item must not be sold to any third party vendors.

TRAF1 is a signaling adaptor known for its role in tumour necrosis factor receptor (TNFR)-induced cell survival. This thesis explores the role of TRAF1 in human health and several disease states, including autoimmunity, infectious disease and cancer. Genome wide association studies identified an association between single nucleotide polymorphisms (SNPs) in the TRAF1 gene with increased incidence of rheumatoid arthritis (RA) and other autoimmune diseases. I provide a compelling explanation for how this SNP could contribute to the increased incidence and severity of RA and other inflammatory diseases by presenting evidence that healthy donors with the RA-associated SNP express less TRAF1 protein but higher levels of inflammatory cytokines due to an unexpected role for TRAF1 in negatively-regulating TLR signaling.In the context of infectious disease, it had been shown that the loss of TRAF1 from chronically stimulated CD8 T cells results in desensitization of the 4-1BB signaling pathway, thereby contributing to T cell exhaustion during chronic infection. Previous results showed that IL-7 can restore TRAF1 expression in virus specific CD8 T cells in mice, rendering them sensitive to anti-4-1BB agonist therapy. I show that IL-7 therapy in antiretroviral therapy treated patients induces sustained changes in the number and phenotype of HIV-specific T cells, including increased levels of phospho-ribosomal protein S6 and increased frequency of TRAF1+ cells. TNFR family members such as CD40 play important roles in driving NF-B activation in B cell related cancers, including chronic lymphocytic leukemia (CLL). Here I present evidence that the protein kinase C related kinase, PKN1, is required to protect the pro-survival signaling adaptor TRAF1 from degradation during constitutive CD40 signaling. Accordingly, treatment of patient CLL cells with a PKN1 inhibitor lowered TRAF1 and other survival molecules and resulted in increased cell death. These findings provide proof of concept for PKN1 as a novel target for killing CLL cells. Altogether, these studies have advanced our understanding of the impact of TRAF1 in human disease as an important molecule that can limit inflammation and contribute to control of chronic viral infection. My findings also identify TRAF1 as a potential biomarker and may inform the development of a novel therapy for human B cell malignancies.

ISBN: 9781392634585Subjects--Topical Terms:

611031
Immunology.
Subjects--Index Terms:

Chronic lymphocytic leukemia

TRAF1 in Human Health and Disease.
LDR:03539nmm a2200385 4500 001 2272850
005 20201105110240.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9781392634585
035 $a (MiAaPQ)AAI27540072
035 $a AAI27540072
040 $a MiAaPQ $c MiAaPQ
100 1 $a Edilova, Maria . $3 3550274
245 1 0 $a TRAF1 in Human Health and Disease.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 175 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-05, Section: B.
500 $a Advisor: Watts, Tania H.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2019.
506 $a This item must not be sold to any third party vendors.
520 $a TRAF1 is a signaling adaptor known for its role in tumour necrosis factor receptor (TNFR)-induced cell survival. This thesis explores the role of TRAF1 in human health and several disease states, including autoimmunity, infectious disease and cancer. Genome wide association studies identified an association between single nucleotide polymorphisms (SNPs) in the TRAF1 gene with increased incidence of rheumatoid arthritis (RA) and other autoimmune diseases. I provide a compelling explanation for how this SNP could contribute to the increased incidence and severity of RA and other inflammatory diseases by presenting evidence that healthy donors with the RA-associated SNP express less TRAF1 protein but higher levels of inflammatory cytokines due to an unexpected role for TRAF1 in negatively-regulating TLR signaling.In the context of infectious disease, it had been shown that the loss of TRAF1 from chronically stimulated CD8 T cells results in desensitization of the 4-1BB signaling pathway, thereby contributing to T cell exhaustion during chronic infection. Previous results showed that IL-7 can restore TRAF1 expression in virus specific CD8 T cells in mice, rendering them sensitive to anti-4-1BB agonist therapy. I show that IL-7 therapy in antiretroviral therapy treated patients induces sustained changes in the number and phenotype of HIV-specific T cells, including increased levels of phospho-ribosomal protein S6 and increased frequency of TRAF1+ cells. TNFR family members such as CD40 play important roles in driving NF-B activation in B cell related cancers, including chronic lymphocytic leukemia (CLL). Here I present evidence that the protein kinase C related kinase, PKN1, is required to protect the pro-survival signaling adaptor TRAF1 from degradation during constitutive CD40 signaling. Accordingly, treatment of patient CLL cells with a PKN1 inhibitor lowered TRAF1 and other survival molecules and resulted in increased cell death. These findings provide proof of concept for PKN1 as a novel target for killing CLL cells. Altogether, these studies have advanced our understanding of the impact of TRAF1 in human disease as an important molecule that can limit inflammation and contribute to control of chronic viral infection. My findings also identify TRAF1 as a potential biomarker and may inform the development of a novel therapy for human B cell malignancies.
590 $a School code: 0779.
650 4 $a Immunology. $3 611031
650 4 $a Cellular biology. $3 3172791
650 4 $a Virology. $3 642304
653 $a Chronic lymphocytic leukemia
653 $a HIV
653 $a Human immunology
653 $a Rheumatoid arthritis
653 $a TNFR
653 $a TRAF1
690 $a 0982
690 $a 0379
690 $a 0720
710 2 $a University of Toronto (Canada). $b Immunology. $3 3193210
773 0 $t Dissertations Abstracts International $g 81-05B.
790 $a 0779
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27540072